Classification Donald LAURENT BU MASTERBATCHES 22.10.2012 PRÉSENTATION CLARIANT.

Présentation au sujet: "Classification Donald LAURENT BU MASTERBATCHES 22.10.2012 PRÉSENTATION CLARIANT."— Transcription de la présentation:

1 Classification Donald LAURENT BU MASTERBATCHES 22.10.2012 PRÉSENTATION CLARIANT

2 Donald LAURENT, BU MASTERBATCHES, 22.10.2012 Effectifs 31.12.2014 1 547 CA 2014 (CHF m) Clariant Masterbatches Europe en quelques chiffres Public 2 1 233 3 943 Effectifs 31.12.2014 515 Sites de production 5714 BU Masterbatches*RBL Europe* * BL Healthcare Packaging incluse

3 Donald LAURENT, BU MASTERBATCHES, 22.10.2012 Notre présence en Europe et dans le Monde Public 3 115 000 Sites de production et bureaux de ventes* Tonnes de capacité de production en 2014* 19 Centre de Design & Project House 1 & 1 Site de production RBL NorAm 11 sites RBL LatAm 7 sites RBL IMEA 10 sites RBL APAC 12 sites RBL Europe 13 sites Clariant Masterbatches dans le monde: (*BL Healthcare Packaging exclus) Bureau de ventes   Healthcare Packaging

4 Donald LAURENT, BU MASTERBATCHES, 22.10.2012 Vos Marchés… Public 4 EMBALLAGE BIENS DE CONSOMMATION DURABLES FIBRES AUTOMOBILE MEDICAL & PHARMA

5 Donald LAURENT, BU MASTERBATCHES, 22.10.2012 … Les Solutions de Clariant Public 5 MEVOPUR ® Gamme de solutions dédiées au secteur médical et pharmaceutique RENOL ® Mélanges maîtres de couleur et compounds pour les non oléofines REMAFIN ® Mélanges maîtres de couleur et compounds pour les oléofines ENIGMA ® Effets spéciaux HYDRO- CEROL ® Agents gonflants HIFORMER ® Systèmes de mélanges maîtres liquides CESA ® Mélanges maîtres d’additifs standards et de spécialité OMNI- COLOR ® Mélanges maîtres multifonctionnels

6 Donald LAURENT, BU MASTERBATCHES, 22.10.2012 Disclaimer Public 6 This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company's ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.